Pharmacology seminar: Tumour vascular biology, targeted anticancer delivery and personalised medicine; connecting the dots Event as iCalendar

10 July 2013

1 - 2pm

Venue: Seminar Room 501-505, Building 501, 85 Park Road, Grafton

Dr Gerish had basic training as an oncologist and practiced clinical oncology from 1995-2006.  He received his research training in the laboratory of Professor Hiroshi Maeda, who developed the first approved nanomedicine (SMANCS) for treatment of liver cancer.  As a JSPS postdoctoral fellow, he developed and carried out in vivo pharmacokinetic studies of various tumours targeted micelles.  From 2008-2011, he coordinated in vivo experiments on polymeric drug delivery platforms for solid tumour therapy in the Department of Pharmaceutical Chemistry, Utah University.  He moved to the University of Otago in 2011 and is currently focusing on developing novel nano delivery systems for selective drug delivery.

Presented by: Dr Khaled Gerish, Department of Pharmacology & Toxicology, University of Otago


For more information please contact:

Kavita Hussein Email: k.hussein@auckland.ac.nz Phone: 64 9 373 7599 Ext 86733